Early Access — free while we kick the tires
EdgarHawk

BTMD biote Corp. Insider Trading

12 filings analyzed · Latest 2025-05-08
Insider buys
12
Insider sells
0
Unique insiders
5
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

May 2025
2025-05-08
high
447,714 shares
$1,461,373
@ $3.26
Significance 6/10

Guines LLC (10% owner) buys 447,714 shares across 2 transactions totaling $1,461,372.93 at blended avg $3.26, raising stake 10.7% to 4.62M shares

Guines LLC, a 10% owner of BTMD, executed two separate purchases totaling 447,714 shares for $1,461,372.93 on May 6–7, 2025, at a blended average price of $3.26. This represents a 10.7% increase in the filer's holdings from 4,175,034 to 4.62M shares. The current price of $3.74 is -55.3% from the 52-week high of $8.36, though it has risen 15.1% over the prior 30 days. Notably, Guines LLC has executed four other buys at BTMD within the prior three weeks (April 9, 16, 17, 21, and 30), establishing a pattern of repeated accumulation at this ticker. The company's fundamentals show revenue of $51.4M with net income of $10.7M (latest quarter) and a 6.4% annual revenue growth rate, but trading at a P/E of 31.17. While the cross-ticker track record shows a 6.2% average 30-day return on 13 prior buys, none of the five recent BTMD-specific purchases are yet measurable at the 90-day mark, so outcome validation at this ticker is unavailable.

2025-05-02
medium
1,933 shares
$6,371
@ $3.30
Significance 4/10

Guines LLC (10% Owner) purchased 1,933 shares of BTMD at $3.30 on 2025-04-30, totaling $6,371.17; fifth buy in three weeks

Guines LLC, a 10% shareholder, executed its fifth open-market purchase of BTMD in as many days (2025-04-08 through 2025-04-30), acquiring 1,933 shares at $3.30 on the most recent date. The cumulative pattern indicates sustained buying at consistent price levels during a period when the stock has declined 31.6% over 90 days and trades 58.4% below its 52-week high of $8.36. Across the insider's broader open-market history spanning multiple tickers, prior buys averaged a +2.2% 30-day return; however, none of the five same-ticker purchases at BTMD have yet reached 90-day measurement windows to assess timing accuracy. The company fundamentals remain solid—$51.4M quarterly revenue, $10.7M net income, +6.4% annual growth, and a P/E of 29.00—providing context for the accumulation despite recent price weakness. The high frequency of purchases in a compressed timeframe warrants closer examination of market conditions and the insider's stated rationale.

April 2025
2025-04-23
medium
8,801 shares
$28,782
@ $3.27
Significance 5/10

10% owner Guines LLC bought 8,801 shares of BTMD at $3.27 on 2025-04-21; stock down 59.0% from 52-week high of $8.36

Guines LLC, a 10% owner, purchased 8,801 shares at $3.27 on 2025-04-21 as part of a cluster of five buys at BTMD executed between 2025-04-07 and 2025-04-21. The company's financial position shows stable fundamentals: $51.4M in quarterly revenue, $10.7M net income, and 6.4% annual revenue growth. However, the stock has deteriorated significantly, trading at $3.43 currently and down 59.0% from its 52-week high of $8.36, with a 30-day decline of 12.0%. The insider's cross-ticker track record shows 11 prior open-market buys with an average 30-day return of +2.2%, but outcomes at this specific ticker are not yet measurable given the transactions occurred in April 2025. The timing pattern across the same-ticker history shows none of 0 prior buys were well-timed at the 90-day mark, a neutral baseline, though the current five-trade sequence began while the stock was already under significant pressure.

2025-04-18
medium
7,874 shares
$25,906
@ $3.29
Significance 4/10

10% owner Guines LLC buys 7,874 shares at $3.29 across 2 transactions as stock falls 60.5% from 52-week high.

Guines LLC, a 10% owner, executed 2 purchases totaling 7,874 shares for $25,906.27 at $3.29 on 2025-04-16 and 2025-04-17, increasing holdings to 4,164,300 shares. The transaction occurs amid sharp recent weakness: the stock has declined 60.5% from its 52-week high and is down 18.9% over the past 30 days and 41.5% over 90 days. However, this purchase is part of a much larger pattern at this ticker—Guines has executed 5 prior buys at BTMD on 2025-04-03, 2025-04-04, 2025-04-07, 2025-04-08, and 2025-04-09, all within the past two weeks. The company's fundamentals show $51.4M in latest quarterly revenue and $10.7M net income with 6.4% annual growth, supporting a P/E of 27.50. Investors should monitor whether this rapid accumulation during a period of significant stock depreciation reflects a contrarian assessment of value or merely dollar-cost averaging during a broader decline.

2025-04-10
high
48,439 shares
$155,388
@ $3.21
Significance 6/10

10% owner Guines LLC purchased 48,439 shares at $3.21 in 2 transactions on 2025-04-08 and 2025-04-09; stock -59.9% from 52-week high.

Guines LLC, holding 4,156,426 shares post-transaction, executed 2 separate open-market purchases totaling 48,439 shares for $155,387.69 at $3.21 per share on consecutive trading days. The purchases occurred while BTMD trades at $3.35 current price, down -59.9% from its 52-week high of $8.36 and -18.9% over the trailing 30 days. The insider has 5 prior buys at this ticker within the past month (2025-03-17 through 2025-04-07), all with outcomes not yet measurable. Fundamentally, the company reported $51.4M quarterly revenue with $10.7M net income and trades at a P/E of 27.92 on a $195.0M market cap. The timing and persistence of accumulation through a sharp price decline merits investor attention to whether this reflects confidence in a turnaround or merely routine rebalancing.

2025-04-07
medium
74,440 shares
$237,406
@ $3.19
Significance 6/10

Guines LLC (10% Owner) bought 74,440 shares across 3 transactions at BTMD for $237,405.51 at blended $3.19, amid -23.7% 30-day and -45.1% 90-day price declines.

Guines LLC executed 3 separate purchases totaling 74,440 shares for $237,405.51 between April 3–7, with a blended average price of $3.19 per share. The stock has fallen -23.7% over the past 30 days and -45.1% over 90 days, trading at $3.25 against a 52-week high of $8.36 (-61.1% from peak). This acquisition increases the filer's holdings to 4,107,987 shares, a +1.8% net addition to pre-transaction holdings of 4,033,547 shares. The company reported $51.4M in quarterly revenue, $10.7M net income, +6.4% annual revenue growth, and a P/E of 27.08. Guines LLC's same-ticker trading record at BTMD shows 4 prior buy transactions in March 2025, all too recent to measure 90-day outcomes. The timing of these purchases during a sustained price decline merits observation of whether this accumulation reflects informed conviction or mechanical portfolio rebalancing unrelated to company fundamentals.

2025-04-02
medium
106,000 shares
$351,920
@ $3.32
Significance 6/10

10% owner Guines LLC buys 106,000 shares of BTMD at $3.32; stock down -58.6% from 52-week high, now trading at $3.46

Guines LLC, a 10% owner of biote Corp., purchased 106,000 shares at $3.32 on 2025-03-31, bringing total holdings to 4,033,547 shares. This represents an accumulation during a period of significant weakness: the stock has declined -58.6% from its 52-week high of $8.36 and is down -18.4% over the past 30 days. The purchase comes on the heels of three prior buys at BTMD within the preceding two weeks (2025-03-13, -14, and -17), suggesting a pattern of repeated accumulation as the stock price has contracted. The company's fundamentals show modest growth (revenue $51.4M, net income $10.7M, +6.4% annual revenue growth) with a P/E of 28.83, which remains elevated relative to the current depressed valuation. Given the compressed price action and concentrated buying pattern by a significant shareholder, investors should track whether these purchases signal conviction in the underlying business or simply reflect opportunistic deployment at lower prices.

March 2025
2025-03-19
high
75,000 shares
$296,042
@ $3.95
Significance 7/10

Director Andrew R. Heyer bought 75,000 shares at $3.95; cluster pattern with 4 other insiders buying within 14 days.

Director Andrew R. Heyer executed 2 separate purchases totaling 75,000 shares for $296,042.50 at a blended average price of $3.95, increasing his holdings by 25.4% to 370,201 shares. The transaction occurred at a price -49.5% below the 52-week high of $8.36, during a period when the stock has declined 7.9% over the past 30 days and 26.7% over 90 days. The transaction is part of a broader insider cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated confidence despite recent price weakness. Across Heyer's cross-ticker track record, his 13 prior open-market buys averaged +8.0% returns over 30 days and +16.5% over 90 days (53.85% win rate), though this provides limited evidence for predictive power at BTMD specifically.

2025-03-18
high
38,104 shares
$147,844
@ $3.88
Significance 7/10

Director Stephen Mark Cone bought 38,104 shares of BTMD at $3.88 on 2025-03-17; cluster of 4 other insider buys in past 14 days

Stephen Mark Cone, a director, purchased 38,104 shares at $3.88 on 2025-03-17, increasing his holdings by 31.0% to 160,829 shares post-transaction. This buy occurs within a cluster pattern: 4 other insiders have also purchased shares within the past 14 days. The stock is currently trading at $4.07, down 51.3% from its 52-week high of $8.36 and down 34.1% over the past 90 days, suggesting the purchase was made into a declining price trend. The company reported net income of $10.7M against revenue of $51.4M (latest quarter), with annual revenue growth of 6.4% and a P/E of 33.92, indicating the company remains operationally profitable despite recent equity price weakness.

2025-03-18
high
Chief Executive Officer
37,595 shares
$145,493
@ $3.87
Significance 7/10

CEO Christensen bought 37,595 shares at $3.87 amid cluster buy pattern; stock down -51.3% from 52-week high

CEO Bret Christensen purchased 37,595 shares at $3.87, establishing a new position of 37,595 shares from zero prior holdings. This purchase occurred alongside a broader cluster pattern in which 4 other insiders also bought within the past 14 days, suggesting coordinated insider activity. The stock has declined significantly, trading at -51.3% from its 52-week high of $8.36 and down -11.1% over the prior 30 days, creating a context of depressed pricing relative to recent history. Despite the price weakness, BTMD maintains positive fundamentals with $51.4M in quarterly revenue and $10.7M net income; the P/E of 33.92 and +6.4% annual revenue growth indicate the company is generating earnings and growing, yet the market has repriced the equity sharply downward.

Insiders here also file at

More Chemicals and Allied Products companies

Get alerts for BTMD

Add BTMD to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access